Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€87.46

€87.46

-0.770%
-0.68
-0.770%
€126.00
 
20.06.25 / Tradegate WKN: A2AA7B / Name: Axsome / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Axsome Therapeutics Inc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Axsome

sharewise wants to provide you with the best news and tools for Axsome, so we directly link to the best financial data sources.

News

Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis: https://g.foolcdn.com/editorial/images/818028/copy-of-tmf-yt-thumbnails-58.jpg
Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis

Explore the exciting world of Axsome Therapeutics (NASDAQ: AXSM) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years: https://g.foolcdn.com/editorial/images/817535/person-sitting-at-a-desk-looking-at-two-monitors.jpg
Prediction: These 2 Stocks Will Outperform the Market in the Next Five Years

Regardless of how stocks are performing right now, history tells us that the market tends to generate solid returns over long periods. Investors can do even better than the average market

Why Shares of Axsome Therapeutics Slumped Today: https://g.foolcdn.com/editorial/images/813308/best-stocks-to-buy.jpg
Why Shares of Axsome Therapeutics Slumped Today

Shares of biopharmaceutical company Axsome Therapeutics (NASDAQ: AXSM) had declined 6% at 11 a.m. ET today. The slump comes after the company announced the results of a phase 3 trial of solriamfetol

Axsome Therapeutics (AXSM) Q4 2024 Earnings Call Transcript
Axsome Therapeutics (AXSM) Q4 2024 Earnings Call Transcript

Image source: The Motley Fool.

Axsome Therapeutics (NASDAQ: AXSM)Q4 2024 Earnings CallFeb 18, 2025, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

Axsome Therapeutics Revenue Surges 66%
Axsome Therapeutics Revenue Surges 66%

Biopharmaceutical firm Axsome Therapeutics (NASDAQ:AXSM) reported mixed fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 18. The company achieved substantial revenue growth, with sales

This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?
This Stock Is Already Up by 55% in 2025: Is It Too Late to Buy?

It's only mid-February, but as of this writing biotech company Axsome Therapeutics (NASDAQ: AXSM) is up by 55% year to date. Substantial stock-market gains over short periods aren't that rare in the

Why Axsome Therapeutics Stock Is Soaring Today
Why Axsome Therapeutics Stock Is Soaring Today

Shares of Axsome Therapeutics (NASDAQ: AXSM) are up on Tuesday. The company's stock gained 4.1% as of 10:20 a.m. ET, but was up as much as 5.6% earlier in the day. The jump comes as the S&P 500

Why Axsome Therapeutics Stock Is Skyrocketing Today
Why Axsome Therapeutics Stock Is Skyrocketing Today

Shares of Axsome Therapeutics (NASDAQ: AXSM) are flying higher on Monday. The company's stock is up 24.7% as of 1:10 p.m. ET, gaining as much as 25% earlier in the day. The move up comes as the S&P